TMRW Life Sciences Modernizes In Vitro Fertilization
TMRW Life Sciences Inc CEO Tara Comonte explains how her company uses technology to advance in vitro fertilization. She also talks about her company raising $105 million in series C funding. She speaks with Caroline Hyde on "Bloomberg Technology." (Source: Bloomberg)